跳转至内容
Merck
CN
  • Calcium supplementation during sepsis exacerbates organ failure and mortality via calcium/calmodulin-dependent protein kinase kinase signaling.

Calcium supplementation during sepsis exacerbates organ failure and mortality via calcium/calmodulin-dependent protein kinase kinase signaling.

Critical care medicine (2013-07-28)
Richard D Collage, Gina M Howell, Xianghong Zhang, Jennifer L Stripay, Janet S Lee, Derek C Angus, Matthew R Rosengart
摘要

Calcium plays an essential role in nearly all cellular processes. As such, cellular and systemic calcium concentrations are tightly regulated. During sepsis, derangements in such tight regulation frequently occur, and treating hypocalcemia with parenteral calcium administration remains the current practice guideline. We investigated whether calcium administration worsens mortality and organ dysfunction using an experimental murine model of sepsis and explored the mechanistic role of the family of calcium/calmodulin-dependent protein kinases in mediating these physiological effects. To highlight the biological relevance of these observations, we conducted a translational study of the association between calcium administration, organ dysfunction, and mortality among a cohort of critically ill septic ICU patients. Prospective, randomized controlled experimental murine study and observational clinical cohort analysis. University research laboratory and eight ICUs at a tertiary care center. A cohort of 870 septic ICU patients. C57Bl/6 and CaMKK mice. Mice underwent cecal ligation and puncture polymicrobial sepsis and were administered with calcium chloride (0.25 or 0.25 mg/kg) or normal saline. Administering calcium chloride to septic C57Bl/6 mice heightened systemic inflammation and vascular leak, exacerbated hepatic and renal dysfunction, and increased mortality. These events were significantly attenuated in CaMKK mice. In a risk-adjusted analysis of septic patients, calcium administration was associated with an increased risk of death, odds ratio 1.92 (95% CI, 1.00-3.68; p = 0.049), a significant increase in the risk of renal dysfunction, odds ratio 4.74 (95% CI, 2.48-9.08; p < 0.001), and a significant reduction in ventilator-free days, mean decrease 3.29 days (0.50-6.08 days; p = 0.02). Derangements in calcium homeostasis occur during sepsis that is sensitive to calcium administration. This altered calcium signaling, transduced by the calmodulin-dependent protein kinase kinase cascade, mediates heightened inflammation and vascular leak that culminates in elevated organ dysfunction and mortality. In the clinical management of septic patients, calcium supplementation provides no benefit and may impose harm.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
氯化钙 二水合物, ACS reagent, ≥99%
Sigma-Aldrich
氯化钙 二水合物, ReagentPlus®, ≥99.0%
Sigma-Aldrich
氯化钙 溶液, BioUltra, Molecular Biology, ~1 M in H2O
Sigma-Aldrich
氯化钙 二水合物, Molecular Biology, ≥99.0%
Sigma-Aldrich
氯化钙, anhydrous, BioReagent, suitable for insect cell culture, suitable for plant cell culture, ≥96.0%
Sigma-Aldrich
氯化钙 二水合物, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99.0%
Sigma-Aldrich
氯化钙, powder, 99.99% trace metals basis
Sigma-Aldrich
氯化钙 二水合物, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99%
Sigma-Aldrich
氯化钙
Sigma-Aldrich
氯化钙 二水合物, BioUltra, Molecular Biology, ≥99.5% (KT)
Sigma-Aldrich
氯化钙 二水合物, tested according to Ph. Eur.
Sigma-Aldrich
氯化钙, AnhydroBeads, −10 mesh, ≥99.9% trace metals basis
Sigma-Aldrich
氯化钙 二水合物, BioXtra, ≥99.0%
Sigma-Aldrich
氯化钙 二水合物, puriss., meets analytical specification of Ph. Eur., USP, FCC, E509, 99-103%, ≤0.0001% Al
Supelco
AAS 钙标准品, analytical standard, 1.000 g/L Ca2+ in hydrochloric acid, traceable to BAM
Supelco
用于 ISE 的钙离子溶液, 0.1 M Ca, analytical standard (for ion-selective electrodes)
Sigma-Aldrich
氯化钙, AnhydroBeads, −10 mesh, ≥99.99% trace metals basis
Sigma-Aldrich
氯化钙 二水合物, Vetec, reagent grade, 99%
Sigma-Aldrich
氯化钙, Vetec, reagent grade, 96%